Abstract:Succinate is a potent immune signalling molecule that is present in the mammalian gut and within macrophages. Both of these infection niches are colonised by the pathogenic bacterium Salmonella enterica serovar Typhimurium during infection. Succinate is a C 4 -dicarboyxlate that can serve as a source of carbon for bacteria. When succinate is provided as the sole carbon source for in vitro cultivation, Salmonella and other enteric bacteria exhibit a slow growth rate and a long lag phase. This growth inhibition phenomenon was known to involve the sigma factor RpoS, but the genetic basis of the repression of bacterial succinate utilisation was poorly understood. Here, we use an experimental evolution approach to isolate fast-growing mutants during growth of S . Typhimurium on succinate containing minimal medium. Our approach reveals novel RpoS-independent systems that inhibit succinate utilisation. The CspC RNA binding protein restricts succinate utilisation, an inhibition that is antagonised by high levels of the small regulatory RNA (sRNA) OxyS. We discovered that the Fe-S cluster regulatory protein IscR inhibits succinate utilisation by repressing the C 4 -dicarboyxlate transporter DctA. Furthermore, the ribose operon repressor RbsR is required for the complete RpoS-driven repression of succinate utilisation, suggesting a novel mechanism of RpoS regulation. Our discoveries shed light on the redundant regulatory systems that tightly regulate the utilisation of succinate. We speculate that the control of central carbon metabolism by multiple regulatory systems in Salmonella governs the infection niche-specific utilisation of succinate. During infection, Salmonella enterica serovar Typhimurium must efficiently utilise the nutrients provided by the host and the microbiota. Within host niches colonised by Salmonella , key carbon source is succinate, which is abundant in both the gut and within macrophages. Although S . Typhimurium possesses all the molecular machinery to import and catabolise succinate, the utilisation of this carbon source is strongly inhibited under laboratory conditions. Here, we have used diverse genetic approaches to discover that several distinct genetic regulatory systems act in concert to repress succinate utilisation by Salmonella . Our study sheds new light on how carbon source utilisation is managed by this important model enteropathogenic bacterium.

Succinate and inosine coordinate innate immune response to bacterial infection

A Metabolite from Commensal Candida Albicans Enhances the Bactericidal Activity of Macrophages and Protects Against Sepsis

Serine Metabolism Tunes Immune Responses to Promote Oreochromis Niloticus Survival Upon Edwardsiella Tarda Infection.

Itaconate is a Lysosomal Inducer That Promotes Antibacterial Innate Immunity.

Succinate Promotes Phagocytosis of Monocytes/Macrophages in Teleost Fish

Intestinal Metabolites Influence Macrophage Phagocytosis and Clearance of Bacterial Infection

Itaconate Uptake Via SLC13A3 Improves Hepatic Antibacterial Innate Immunity

Succinate metabolism and its regulation of host-microbe interactions

Succinate utilisation by Salmonella is inhibited by multiple regulatory systems

Succinate Is a Natural Suppressor of Antiviral Immune Response by Targeting MAVS

Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention

Increased Susceptibility of S1PR3-Deficient Mice to Escherichia Coli Sepsis is Associated with an Impaired Bactericidal Activity in Macrophage

Succinate as a signaling molecule in the mediation of liver diseases

Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer

Switch of NAD Salvage to De Novo Biosynthesis Sustains SIRT1-RelB-Dependent Inflammatory Tolerance

Gut microbiota-derived succinate aggravates acute lung injury after intestinal ischaemia/reperfusion in mice

Inosine reverses multidrug resistance in Gram-negative bacteria carrying mobilized RND-type efflux pump gene cluster tmexCD-toprJ

4-Octyl Itaconate As a Metabolite Derivative Inhibits Inflammation Via Alkylation of STING

Metabolic Modulation-Mediated Antibiotic and Immune Activation for Treatment of Chronic Lung Infections

Roles of Critical Amino Acids Metabolism in The Interactions Between Intracellular Bacterial Infection and Macrophage Function

Switch off "parallel Circuit": Insight of New Strategy of Simultaneously Suppressing Canonical and Noncanonical Inflammation Activation in Endotoxemic Mice.